Inventor

HAYDEN-LEDBETTER MARTHA

US16 patents

⚠️ This page may combine multiple inventors who share the name “HAYDEN-LEDBETTER MARTHA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNIV WASHINGTON

6 patents

US10000745B2Jun 19, 2018

LEDBETTER JEFFREY A

3 patents

US8841416B2Sep 23, 2014

Therapeutic nuclease compositions and methods

LEDBETTER JEFFREY A34 citations97

US10202588B2Feb 12, 2019

Therapeutic nuclease compositions and methods

LEDBETTER JEFFREY A9 citations83

US8853366B2Oct 7, 2014

Binding domain-immunoglobulin fusion proteins

LEDBETTER JEFFREY A2 citations62

TRUBION PHARMACEUTICALS INC

2 patents

US7118751B1Oct 10, 2006

DNA vaccines encoding antigen linked to a domain that binds CD40

TRUBION PHARMACEUTICALS INC92 citations97

US7829084B2Nov 9, 2010

Binding constructs and methods for use thereof

TRUBION PHARMACEUTICALS INC49 citations93

PACIFIC NORTHWEST RES INST

1 patent

US7270960B2Sep 18, 2007

Diagnosis of ovarian carcinomas

PACIFIC NORTHWEST RES INST33 citations92

THE UNIV OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION

1 patent

US9416188B2Aug 16, 2016

Molecules that bind CD180, compositions and methods of use

THE UNIV OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION8 citations78

HAYDEN-LEDBETTER MARTHA

1 patent

US9260529B2Feb 16, 2016

Molecules that bind CD180, compositions and methods of use

HAYDEN-LEDBETTER MARTHA9 citations77

UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION

1 patent

US12435322B2Oct 7, 2025

Therapeutic nuclease compositions and methods

UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION0 citations62

HELLSTROM INGEGERD

1 patent

US9090712B2Jul 28, 2015

Diagnosis of carcinomas

HELLSTROM INGEGERD1 citations48